BML-190
BML-190 is a selective CB2 receptor inverse agonist with a Ki of 435 nM, exhibiting 50-fold selectivity over the CB1 receptor. This compound is a valuable research tool for studying CB2 receptor function in both in vitro and in vivo models of inflammation and neuropathic pain.
Product Specifications
CAS Number
2854-32-2
Product Name Alternative
CB, CB2, BML 190, BML190, BML-190, Cannabinoid Receptor, CannabinoidReceptor, Inhibitor, inhibit, Indomethacin morpholinylamide, IMMA
Field of Research
Pharmacology & Drug Discovery
Purity
97.70% (May vary between batches)
Solubility
DMSO:21 mg/mL (49.19 mM) ;10% DMSO+90% Corn Oil:2 mg/mL (4.69 mM) ; H2O:< 1 mg/mL (insoluble or slightly soluble) ; Ethanol:< 1 mg/mL (insoluble or slightly soluble)
Smiles
COc1ccc2n (C (=O) c3ccc (Cl) cc3) c (C) c (CC (=O) N3CCOCC3) c2c1
Molecular Formula
C23H23ClN2O4
Molecular Weight
426.89
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog